These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9360575)

  • 1. Recombinant tissue plasminogen activator: in my community hospital ED, will early administration of rt-PA to patients with the initial diagnosis of acute ischemic stroke reduce mortality and disability?
    Wyer PC; Osborn HH
    Ann Emerg Med; 1997 Nov; 30(5):629-38. PubMed ID: 9360575
    [No Abstract]   [Full Text] [Related]  

  • 2. Contemporary acute ischemic stroke therapy with intravenous recombinant tissue plasminogen activator.
    Frank JI
    Clin Neurosurg; 2000; 46():261-6. PubMed ID: 10944682
    [No Abstract]   [Full Text] [Related]  

  • 3. Total quality improvement method for reduction of delays between emergency department admission and treatment of acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group.
    Tilley BC; Lyden PD; Brott TG; Lu M; Levine SR; Welch KM
    Arch Neurol; 1997 Dec; 54(12):1466-74. PubMed ID: 9400355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview: hyperacute rt-PA stroke treatment. The NINDS rt-PA Stroke Study Group.
    Donnarumma R; Kongable G; Barch C; Braimah J; Bratina P; Daley S; Rapp K; Sailor S; Spilker J
    J Neurosci Nurs; 1997 Dec; 29(6):351-5. PubMed ID: 9479655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperacute stroke therapy with tissue plasminogen activator.
    Alberts MJ
    Am J Cardiol; 1997 Aug; 80(4C):29D-34D; discussion 35D-39D. PubMed ID: 9284041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment with intravenous rt-PA in a general hospital context: A review of the Saint-Jean Hospital experience from Perpignan, France].
    Sablot D; Cassarini JF; Akouz A; Benejean JM; Leibinger F; Faillie X; Vidry E; Ayrignac X; Castro S; Sinaya L; Bertrand JL; Garcia Y; Arnoud B; Negre C
    Rev Neurol (Paris); 2006 Nov; 162(11):1109-17. PubMed ID: 17086147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraarterial recombinant tissue plasminogen activator for ischemic stroke: an accelerated dosing regimen.
    Coplin WM; Broderick J; Tomsick TT
    Neurosurgery; 2001 Jul; 49(1):228-9. PubMed ID: 11440452
    [No Abstract]   [Full Text] [Related]  

  • 8. Myths regarding the NINDS rt-PA Stroke Trial: setting the record straight.
    Haley EC; Lewandowski C; Tilley BC
    Ann Emerg Med; 1997 Nov; 30(5):676-82. PubMed ID: 9360581
    [No Abstract]   [Full Text] [Related]  

  • 9. Pathophysiology and mechanisms of acute ischemic stroke. The NINDS rt-PA Stroke Study Group.
    Bratina P; Rapp K; Barch C; Kongable G; Donnarumma R; Spilker J; Daley S; Braimah J; Sailor S
    J Neurosci Nurs; 1997 Dec; 29(6):356-60. PubMed ID: 9479656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How to administer t-PA in acute ischemic stroke.
    Nursing; 1997 Apr; 27(4):32gg. PubMed ID: 9171655
    [No Abstract]   [Full Text] [Related]  

  • 11. The use of intravenous recombinant tissue plasminogen activator in acute ischemic stroke.
    Kahn JH; Viereck J; Kase C; Jeerakathil T; Romero R; Mehta SD; Kociol R; Babikian V
    J Emerg Med; 2005 Oct; 29(3):273-7. PubMed ID: 16183445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-World Outcomes of Acute Ischemic Stroke Treatment with Intravenous Recombinant Tissue Plasminogen Activator.
    Betts KA; Hurley D; Song J; Sajeev G; Guo J; Du EX; Paschoalin M; Wu EQ
    J Stroke Cerebrovasc Dis; 2017 Sep; 26(9):1996-2003. PubMed ID: 28689999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should thrombolytic therapy be the first-line treatment for acute ischemic stroke? t-PA--the best current option for most patients.
    Grotta J
    N Engl J Med; 1997 Oct; 337(18):1310-3. PubMed ID: 9345085
    [No Abstract]   [Full Text] [Related]  

  • 14. US geographic distribution of rt-PA utilization by hospital for acute ischemic stroke.
    Kleindorfer D; Xu Y; Moomaw CJ; Khatri P; Adeoye O; Hornung R
    Stroke; 2009 Nov; 40(11):3580-4. PubMed ID: 19797701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombolysis in acute ischemic stroke.
    Dumo P; Fagan SC; Carhuapoma J
    Am J Health Syst Pharm; 1997 Oct; 54(19):2213-7. PubMed ID: 9331444
    [No Abstract]   [Full Text] [Related]  

  • 16. Recombinant tissue plasminogen activator (rt-PA) utilisation by rural clinicians in acute ischaemic stroke: an audit of current practice and clinical outcomes.
    Williams JM; Navin TJ; Jude MR; Levi CR
    Aust J Rural Health; 2013 Aug; 21(4):203-7. PubMed ID: 24033520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. rtPA in acute ischemic stroke: European perspective.
    Hacke W
    Neurology; 1997 Nov; 49(5 Suppl 4):S60-2. PubMed ID: 9371153
    [No Abstract]   [Full Text] [Related]  

  • 18. Should thrombolytic therapy be the first-line treatment for acute ischemic stroke? Thrombolysis--not a panacea for ischemic stroke.
    Caplan LR; Mohr JP; Kistler JP; Koroshetz W
    N Engl J Med; 1997 Oct; 337(18):1309-10; discussion 1313. PubMed ID: 9345084
    [No Abstract]   [Full Text] [Related]  

  • 19. rtPA in acute ischemic stroke: the North American perspective.
    Morgenstern LB
    Neurology; 1997 Nov; 49(5 Suppl 4):S63-5. PubMed ID: 9371154
    [No Abstract]   [Full Text] [Related]  

  • 20. [Acute embolic stroke treated with rt-PA during elective coronary angiography].
    Ascer E; Lessa I; Caldas JG; Frudit ME; Pereira Mde B; Baruzzi AC
    Arq Bras Cardiol; 1996 Sep; 67(3):171-3. PubMed ID: 9181710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.